ducovest

HHL:CA:TSX-Harvest Healthcare Leaders Income ETF (CAD)

ETF | Sector Equity |

Last Closing

CAD 7.96

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.54M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Currency: CAD

Country : Canada

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-16 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

N/A

 CAD 3.16B
ZWU:CA BMO Covered Call Utilities ETF

N/A

 CAD 1.90B
XIT:CA iShares S&P/TSX Capped Informa..

N/A

 CAD 0.69B
TXF:CA First Asset Tech Giants Covere..

N/A

 CAD 0.68B
HTA:CA Harvest Tech Achievers Growth ..

N/A

 CAD 0.64B
XHC:CA iShares Global Healthcare (CAD..

N/A

 CAD 0.60B
ZUT:CA BMO Equal Weight Utilities Ind..

N/A

 CAD 0.56B
XUT:CA iShares S&P/TSX Capped Utiliti..

N/A

 CAD 0.36B
CWW:CA iShares Global Water Common Cl..

N/A

 CAD 0.34B
COW:CA iShares Global Agriculture Com..

N/A

 CAD 0.28B

ETFs Containing HHL:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.87% 20% F 18% F
Dividend Return 7.34% 93% A 90% A-
Total Return 6.47% 26% F 31% F
Trailing 12 Months  
Capital Gain 4.19% 20% F 24% F
Dividend Return 9.25% 91% A- 91% A-
Total Return 13.43% 29% F 37% F
Trailing 5 Years  
Capital Gain 2.31% 20% F 40% F
Dividend Return 45.05% 91% A- 93% A
Total Return 47.36% 40% F 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 2.51% 20% F 44% F
Dividend Return 9.11% 43% F 60% D-
Total Return 6.60% 100% F 98% N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.92% 89% A- 76% C+
Risk Adjusted Return 102.17% 97% N/A 96% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.